Literature DB >> 23839650

Impact of environmental factors on efficacy of glucocorticoids in Chinese population with systemic lupus erythematosus.

Yan-Feng Zou1, Jian-Hua Xu, Jin-Hui Tao, Sheng-Qian Xu, Shuang Liu, Shan-Yu Chen, Jing Cai, Li Lian, Pei-Ling Chen, De-Guang Wang, Sheng-Xiu Liu, Chun-Mei Liang, Qian-Ling Ye, Guo Tian, Min Wu, Hai-Feng Pan, Fa-Ming Pan, Hong Su, Dong-Qing Ye.   

Abstract

Although glucocorticoids (GCs) are effective in inducing remission in systemic lupus erythematosus (SLE) patients, there is a significant variation in response to therapeutic GCs, and some patients do not achieve full remission. The aim of this study was to explore the impact of environmental factors on the efficacy of GCs in a Chinese population with SLE. This was a prospective cohort study, and a total of 260 SLE patients treated with GCs (prednisone) were followed up for 12 weeks. The efficacy of GCs was measured with the scores on SLE disease activity index. Environmental factors were collected using a questionnaire. Single-variable analysis and multivariate logistic regression analysis were used to discriminate the impact of environmental factors on the efficacy of GCs. Two hundred forty-seven patients (95.00 %) completed the 12-week follow-up. Among these patients, 131 (53.04 %) were classified into sensitive group and 116 (46.96 %) were classified into insensitive group. Results from logistic analysis showed that the following environmental factors were significantly associated with decreased efficacy of GCs: high salt intake (OR = 3.464, 95%CI = 1.481-8.102, P = 0.004), introverted personality (OR = 3.550, 95%CI = 1.901-6.628, P < 0.0001), experience with negative life events (OR = 5.526, 95%CI = 1.612-18.946, P = 0.007), and history of allergy (OR = 2.966, 95%CI = 1.312-6.704, P = 0.009). These results indicate that environmental factors, including salt intake, personality, experience with negative life events, and history of allergy, may play an important role in the efficacy of GCs in the Chinese population with SLE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23839650     DOI: 10.1007/s10753-013-9682-3

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  23 in total

Review 1.  Pharmacogenetics in the rheumatic diseases.

Authors:  Bruce N Cronstein
Journal:  Bull NYU Hosp Jt Dis       Date:  2006

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Effects of negative life events on immune suppression in children and youth infected with human immunodeficiency virus type 1.

Authors:  L C Howland; S L Gortmaker; L M Mofenson; C Spino; J D Gardner; H Gorski; M G Fowler; J Oleske
Journal:  Pediatrics       Date:  2000-09       Impact factor: 7.124

Review 4.  Environmental epidemiology and risk factors for autoimmune disease.

Authors:  M A Dooley; S L Hogan
Journal:  Curr Opin Rheumatol       Date:  2003-03       Impact factor: 5.006

Review 5.  Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus.

Authors:  Andrea T Borchers; Carl L Keen; Yehuda Shoenfeld; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2004-08       Impact factor: 9.754

Review 6.  Salt taste and hypertension: a critical review of the literature.

Authors:  R D Mattes
Journal:  J Chronic Dis       Date:  1984

7.  Psychosocial factors at work, personality traits and depressive symptoms. Longitudinal results from the GAZEL Study.

Authors:  S Paterniti; I Niedhammer; T Lang; S M Consoli
Journal:  Br J Psychiatry       Date:  2002-08       Impact factor: 9.319

8.  Depression as an initial feature of systemic lupus erythematosus? A case report.

Authors:  Gabriela Marian; Elena Alina Nica; Brindusa Ecaterina Ionescu; Doina Gabriela Carlogea
Journal:  J Med Life       Date:  2010 Apr-Jun

9.  Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice.

Authors:  K M Pollard; D L Pearson; P Hultman; T N Deane; U Lindh; D H Kono
Journal:  Environ Health Perspect       Date:  2001-01       Impact factor: 9.031

10.  Personality, socio-economic status and inflammation: cross-sectional, population-based study.

Authors:  Keith Millar; Suzanne M Lloyd; Jennifer S McLean; G David Batty; Harry Burns; Jonathan Cavanagh; Kevin A Deans; Ian Ford; Alex McConnachie; Agnes McGinty; Réne Mõttus; Chris J Packard; Naveed Sattar; Paul G Shiels; Yoga N Velupillai; Carol Tannahill
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more
  6 in total

1.  Associations of HSP90AA2 gene polymorphisms with disease susceptibility, glucocorticoids efficacy and health-related quality of life in Chinese systemic lupus erythematosus patients.

Authors:  Man Zhang; Su-Su Li; Qiao-Mei Xie; Jian-Hua Xu; Xiu-Xiu Sun; Fa-Ming Pan; Sheng-Qian Xu; Sheng-Xiu Liu; Jin-Hui Tao; Shuang Liu; Jing Cai; Pei-Ling Chen; Long Qian; Chun-Huai Wang; Chun-Mei Liang; Hai-Liang Huang; Hai-Feng Pan; Hong Su; Yan-Feng Zou
Journal:  Genes Genomics       Date:  2018-06-15       Impact factor: 1.839

2.  Glucocorticoid receptor genetic polymorphisms is associated with improvement of health-related quality of life in Chinese population with systemic lupus erythematosus.

Authors:  Yan-Feng Zou; Jian-Hua Xu; Fa-Ming Pan; Jin-Hui Tao; Sheng-Qian Xu; Hui Xiao; Shuang Liu; Jing Cai; Li Lian; Pei-Ling Chen; De-Guang Wang; Sheng-Xiu Liu; Chun-Mei Liang; Qian-Ling Ye; Guo Tian; Min Wu; Yuan-Yuan Gu; Hai-Feng Pan; Hong Su; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2015-08-09       Impact factor: 2.980

3.  Copy number variations and polymorphisms in HSP90AB1 and risk of systemic lupus erythematosus and efficacy of glucocorticoids.

Authors:  Man Zhang; Yuanyuan Gu; Shunwei Huang; Qiuyue Lou; Qiaomei Xie; Zhiwei Xu; Yangfan Chen; Faming Pan; Shengqian Xu; Shengxiu Liu; Jinhui Tao; Shuang Liu; Jing Cai; Peiling Chen; Long Qian; Chunhuai Wang; Chunmei Liang; Hailiang Huang; Haifeng Pan; Hong Su; Jian Cheng; Yuzhou Zhang; Wenbiao Hu; Yanfeng Zou
Journal:  J Cell Mol Med       Date:  2019-05-24       Impact factor: 5.310

4.  Methodological quality of cohort study on rheumatic diseases in China: A systematic review.

Authors:  Huan Zhang; Guoxiang Yi; Mingzhu Dai; Yanping Li; Bin Wu
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

Review 5.  Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Nils Rother; Johan van der Vlag
Journal:  Front Immunol       Date:  2015-11-30       Impact factor: 7.561

6.  Single nucleotide polymorphisms of HSP90AA1 gene influence response of SLE patients to glucocorticoids treatment.

Authors:  Yan-Feng Zou; Jian-Hua Xu; Yuan-Yuan Gu; Fa-Ming Pan; Jin-Hui Tao; De-Guang Wang; Sheng-Qian Xu; Hui Xiao; Pei-Ling Chen; Shuang Liu; Jing Cai; Li Lian; Sheng-Xiu Liu; Chun-Mei Liang; Guo Tian; Qian-Ling Ye; Hai-Feng Pan; Hong Su; Dong-Qing Ye
Journal:  Springerplus       Date:  2016-02-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.